ABBV vs GOOG: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Alphabet Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-13.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Alphabet Inc. · Communication Services
$355.03
-17.2% upside to fair value
Grade D
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+1.2%).
GOOG trades at a lower forward P/E
(27.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
GOOG |
| Current Price |
$261.07 |
$355.03 |
| Fair Value Estimate |
$264.30 |
$294.10 |
| Upside to Fair Value |
+1.2%
|
-17.2%
|
| Market Cap |
$461.3B |
$4,320.1B |
| Forward P/E |
128.0x
|
27.0x
|
| EV / EBITDA |
31.0x
|
20.0x
|
| Price / Sales |
7.3x
|
10.2x
|
| Price / FCF |
22.1x
|
67.0x
|
| Revenue Growth YoY |
+12.4%
|
+21.8%
|
| Gross Margin |
70.7%
|
60.4%
|
| Operating Margin |
27.6%
|
32.7%
|
| Return on Equity |
68.0%
|
39.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
1.49%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Alphabet Inc. operates as a global leader in internet content and information services, primarily through its dominant search engine, advertising platforms, and cloud services. The company exhibits high business quality with a durable competitive moat supported by strong network effects, brand recognition, and intangible assets. Alphabet's financials reflect robust profitability with a net margin…
Accumulation Zones
| Metric |
ABBV |
GOOG |
| Zone Low |
$198.23 |
$220.58 |
| Zone High |
$224.66 |
$249.99 |
| In Buy Zone? |
No
|
No
|